EP4034086A1 Pharmaceutical Formulation Patent
Summary
The European Patent Office published application EP4034086A1 on April 8, 2026, filed by Hewlett Healthcare Limited, covering pharmaceutical formulations with IPC classifications including A61K 9/107, A61K 31/352, A61K 31/465, A61K 31/4741, A61K 45/06, A61P 17/00, A61P 17/10, A61P 19/02, A61K 9/00, and A61K 47/10. The patent designates 30+ European member states including DE, FR, GB, IT, NL, ES, and others. Inventor is Nigel Cooper.
What changed
The European Patent Office published patent application EP4034086A1 for Hewlett Healthcare Limited on April 8, 2026. The application covers pharmaceutical formulations including emulsions (A61K 9/107), flavone derivatives (A61K 31/352), and other therapeutic compositions targeting dermatological conditions (A61P 17/00, A61P 17/10) and musculoskeletal disorders (A61P 19/02). The patent designates 30+ European countries.
Pharmaceutical companies and manufacturers operating in the EU should review this publication for freedom-to-operate implications. Competitors developing similar formulations may need to design around this patent or evaluate licensing opportunities. Healthcare providers with R&D operations should monitor the prosecution of this application through to potential grant.
What to do next
- Monitor for updates
- Review for freedom-to-operate considerations
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
FORMULATION
Publication EP4034086A1 Kind: A1 Apr 08, 2026
Applicants
HEWLETT HEALTHCARE LIMITED
Inventors
COOPER, Nigel
IPC Classifications
A61K 9/107 20060101AFI20210402BHEP A61K 31/352 20060101ALI20210402BHEP A61K 31/465 20060101ALI20210402BHEP A61K 31/4741 20060101ALI20210402BHEP A61K 45/06 20060101ALI20210402BHEP A61P 17/00 20060101ALI20210402BHEP A61P 17/10 20060101ALI20210402BHEP A61P 19/02 20060101ALI20210402BHEP A61K 9/00 20060101ALI20210402BHEP A61K 47/10 20170101ALI20210402BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.